Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Current Oncology Reports
|
October 2, 2002
Interferons as antiangiogenic agents
Daniel J Lindner
Molecular and Cellular Biology
|
July 19, 2006
Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4
Zhuo Tang, Joseph A Bauer, Bei Morrison, et al.
The Journal of Biological Chemistry
|
April 16, 2002
Mutational analysis of human thioredoxin reductase 1. Effects on p53-mediated gene expression and interferon and retinoic acid-induced cell death
Xinrong Ma, Junbo Hu, Daniel J Lindner, et al.
Cancer Research
|
July 10, 2007
FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo
Pavan Adiseshaiah, Daniel J Lindner, Dhananjaya V Kalvakolanu, et al.
EJNMMI Radiopharmacy and Chemistry
|
January 30, 2024
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [<sup>68</sup>Ga]Ga-PSMA-11
Steve S Huang, Frank P DiFilippo, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo
Daniel J Lindner, Xinrong Ma, Jiadi Hu, et al.
Anticancer Research
|
December 8, 2020
Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance
Joseph A Bauer, Joseph A Lupica, Joseph A Didonato, et al.
Cancer Chemotherapy and Pharmacology
|
November 15, 2006
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action
Jing Li, Daniel J Lindner, Carol Farver, et al.
British Journal of Cancer
|
December 1, 2020
CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer
Daniel J Lindner, Gary Wildey, Yvonne Parker, et al.
The Biochemical Journal
|
January 7, 2005
Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma
Bei H Morrison, Zhuo Tang, Barbara S Jacobs, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Current Oncology Reports
|
October 2, 2002
Interferons as antiangiogenic agents
Daniel J Lindner
Molecular and Cellular Biology
|
July 19, 2006
Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4
Zhuo Tang, Joseph A Bauer, Bei Morrison, et al.
The Journal of Biological Chemistry
|
April 16, 2002
Mutational analysis of human thioredoxin reductase 1. Effects on p53-mediated gene expression and interferon and retinoic acid-induced cell death
Xinrong Ma, Junbo Hu, Daniel J Lindner, et al.
Cancer Research
|
July 10, 2007
FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo
Pavan Adiseshaiah, Daniel J Lindner, Dhananjaya V Kalvakolanu, et al.
EJNMMI Radiopharmacy and Chemistry
|
January 30, 2024
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [<sup>68</sup>Ga]Ga-PSMA-11
Steve S Huang, Frank P DiFilippo, Daniel J Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2002
Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo
Daniel J Lindner, Xinrong Ma, Jiadi Hu, et al.
Anticancer Research
|
December 8, 2020
Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance
Joseph A Bauer, Joseph A Lupica, Joseph A Didonato, et al.
Cancer Chemotherapy and Pharmacology
|
November 15, 2006
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action
Jing Li, Daniel J Lindner, Carol Farver, et al.
British Journal of Cancer
|
December 1, 2020
CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer
Daniel J Lindner, Gary Wildey, Yvonne Parker, et al.
The Biochemical Journal
|
January 7, 2005
Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma
Bei H Morrison, Zhuo Tang, Barbara S Jacobs, et al.
Page
of 8